13 Best 52-Week Low Stocks to Invest In

Page 10 of 12

​3. Abbott Laboratories (NYSE:ABT)

Price: $106.17

52-Week Range: $105.27 – $141.23

Number of Hedge Fund Holders: 68

​Abbott Laboratories (NYSE:ABT) is one of the Best 52-Week Low Stocks to Invest In. On January 29, Freedom Capital upgraded the stock from Hold to Buy, but lowered the price target from $130 to $120. Earlier, on January 23, UBS reiterated a Buy rating on the stock with a $158 price target.

​The positive ratings come despite the company missing revenue estimates for its fiscal Q4 2025 earnings, released on January 22. The company grew its revenue by 4.24% year-over-year to $11.46 billion, but fell short of the consensus by $342.91 million. The EPS of $1.50 topped expectations by $0.01.

​The analysts at Freedom Capital noted that the weak results were mainly due to the weakness in the company’s Nutrition segment. The firm noted that management expects this weakness to persist throughout the first half of 2026. However, the Medical Devices and Established Pharma segment of Abbott Laboratories (NYSE:ABT) continues to be the key driver of growth and is offsetting challenges in other segments.

​Freedom Capital remains optimistic on the company’s future growth prospects, driven by the integration of Exact Sciences in Q2. The firm finds the company’s 6.5% to 7.5% organic revenue growth guidance for 2026 to be conservative.

​Abbott Laboratories (NYSE:ABT) is a global healthcare company with a broad portfolio spanning diagnostics, medical devices, nutrition, and branded generic medicines.

Page 10 of 12